Citations

Clear

941 citation(s) found for "Tan, MH".

Association of CT-Assessed Dysanapsis With Interstitial Lung Abnormalities in Older Adults
Kim, J. , Anderson, Michaela R. , Hoffman, E.A., Raghu, Ganesh , Ortega, Victor E. , Woodruff, P., Tan, W.-C. , Bourbeau, J., Bossé, Ynuk , Podolanczuk, A., Berger, K., Assayag, Deborah , Manichaikul, Ani , Rich, Stephen S. , Kaner, Robert J. , Hoffman, E.A., Ohar, Jill , Tan, W.C. , Barr, R. Graham , Oelsner, Elizabeth C. , Smith, Benjamin M.

Mayo Clinic

A46. DIAGNOSIS AND MONITORING OF ILD | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A1746-A1746

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1746 Get It

Abstract 13938: Multi-Chamber Strain Characterization Provides Incremental Prognostic Value to Cardiac Damage Staging in Significant Aortic Stenosis
Ye, Zi , Yang, Li‐Tan , Enriquez‐Sarano, Maurice , Michelena, Héctor I.

Mayo Clinic

Circulation | April 23, 2024 | Volume: 144 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.144.suppl_1.13938 Get It

Introduction: The survival impact of impaired multi-chamber longitudinal strain in significant tricuspid aortic valve stenosis(TAV-AS) and its relation to cardiac damage staging(CDS) is unknown. Hypothesis: Impaired strain improves prognostication of CDS in significant TAV-AS. Methods: We performed 2D-semi-automated strain analysis in a retrospective cohort of consecutive patients with TAV-AS with mean pressure gradient≥30mmHg on echocardiogram. The outcome was all-cause death. Cutoffs of impaired left-ventricular global longitudinal strain(
Electrical storm after left ventricular assist device (LVAD) implantation
Karikalan, Suganya Arunachalam , Zhang, Nan , Masry, Hicham El , Killu, Ammar M. , DeSimone, Christopher V. , Deshmukh, Abhishek , Sorajja, Dan , Scott, Luis R. , Cha, Yong‐Mei , Lee, Justin Z. , Karikalan, Suganya , Tan, Min Choon , El Masry, Hicham , Killu, Ammar M , DeSimone, Christopher V , Deshmukh, Abhishek J , Cha, Yong-Mei , McLeod, Christopher J. , Srivathsan, Komandoor

Mayo Clinic

Journal of Cardiovascular Electrophysiology | April 9, 2024 | Volume: 35 | Issue: 6 | Pages: 1196-1202

10.1111/jce.16275 | PMID 38590268 Get It

AbstractIntroductionVentricular tachycardia storm or electrical storm (ES) is a common complication following left ventricular assist device (LVAD) implantation. The factors contributing to ES and outcomes are less studied. The study aimed to determine the factors associated with ES and the probability of survival in patients undergoing LVAD in three tertiary centers over a span of 15 years.MethodsWe performed a retrospective cohort study on all patients who underwent LVAD implantation at the Mayo Clinic (Rochester, Phoenix, and Jacksonville) from January 1, 2006 to December 31, 2020. ES was defined as ≥3 episodes of sustained ventricular tachycardia over a period of 24 h with no identifiable reversible cause. Detailed chart reviews of the electronic health records within the Mayo Clinic and outside medical records were performed.ResultsA total of 883 patients who underwent LVAD implantation were included in our study. ES occurred in 7% (n = 61) of patients with a median of 13 days (interquartile range [IQR]: 5–297 days) following surgery. We found 57% of patients (n = 35) developed ES within 30 days, while 43% (n = 26) patients developed ES at a median of 545 (IQR 152–1032) days after surgery. Following ES, 26% of patients died within 1 year. Patients with ES had a significant association with a history of ventricular arrhythmias and implantable cardioverter defibrillator (ICD) shocks before the procedure. ES was significantly associated with reduced survival compared to patients without ES (hazards ratio [HR]: 1.92, 95% CI: 1.39–2.64, p < .001).ConclusionFollowing LVAD implantation, the rate of ES was 7% with majority of ES occurring within 30 days of LVAD. Risk factors for ES included pre‐implant history of ventricular arrhythmias and ICD shock. ES was significantly associated with reduced survival compared to patients without ES.
Impact of proton PBS machine operating parameters on the effectiveness of layer rescanning for interplay effect mitigation in lung SBRT treatment
Liang, Xiaoying , Flampouri, Stella , Park, Justin C., Yaddanapudi, Sridhar , Tan, Jun , Beltran, Chris , Tan, Jun , Shen, Jiajian , Yaddanapudi, Sridhar , Beltran, Chris J , Liang, Xiaoying , Liu, Chunbo , Shen, Jiajian , Lu, Bo, Furutani, Keith M. , Tan, Jun

Mayo Clinic

Journal of Applied Clinical Medical Physics | April 9, 2024 | Volume: 25 | Issue: 7 | Pages: No page available

10.1002/acm2.14342 | PMID 38590112 Get It

Abstract Background Rescanning is a common technique used in proton pencil beam scanning to mitigate the interplay effect. Advances in machine operating parameters across different generations of particle therapy systems have led to improvements in beam delivery time (BDT). However, the potential impact of these improvements on the effectiveness of rescanning remains an underexplored area in the existing research. Methods We systematically investigated the impact of proton machine operating parameters on the effectiveness of layer rescanning in mitigating interplay effect during lung SBRT treatment, using the CIRS phantom. Focused on the Hitachi synchrotron particle therapy system, we explored machine operating parameters from our institution's current (2015) and upcoming systems (2025A and 2025B). Accumulated dynamic 4D dose were reconstructed to assess the interplay effect and layer rescanning effectiveness. Results Achieving target coverage and dose homogeneity within 2% deviation required 6, 6, and 20 times layer rescanning for the 2015, 2025A, and 2025B machine parameters, respectively. Beyond this point, further increasing the number of layer rescanning did not further improve the dose distribution. BDTs without rescanning were 50.4, 24.4, and 11.4 s for 2015, 2025A, and 2025B, respectively. However, after incorporating proper number of layer rescanning (six for 2015 and 2025A, 20 for 2025B), BDTs increased to 67.0, 39.6, and 42.3 s for 2015, 2025A, and 2025B machine parameters. Our data also demonstrated the potential problem of false negative and false positive if the randomness of the respiratory phase at which the beam is initiated is not considered in the evaluation of interplay effect. Conclusion The effectiveness of layer rescanning for mitigating interplay effect is affected by machine operating parameters. Therefore, past clinical experiences may not be applicable to modern machines.
Trends and Disparities in Valvular Heart Disease Mortality in the United States From 1999 to 2020
Tan, Min Choon , Yeo, Yong Hao , San, Boon Jian , Suleiman, Addi, Lee, Justin Z. , Chatterjee, Arka , Sell‐Dottin, Kristen , Sweeney, John P., Fortuin, F. David , Lee, Kwan , Sell-Dottin, Kristen A , Lee, Kwan S , Yeo, Yong Hao , Fortuin, Floyd David , Tan, Min C

Mayo Clinic

Journal of the American Heart Association | April 8, 2024 | Volume: 13 | Issue: 8 | Pages: No page available

10.1161/jaha.123.030895 | PMID 38587138 Get It

Background Percutaneous heart valve procedures have been increasingly performed over the past decade, yet real‐world mortality data on valvular heart disease (VHD) in the United States remain limited. Methods and Results We queried the Centers for Disease Control and Prevention's Wide‐Ranging Online Data for Epidemiologic Research database among patients ≥15 years old from 1999 to 2020. VHD and its subtypes were listed as the underlying cause of death. We calculated age‐adjusted mortality rate (AAMR) per 100 000 individuals and determined overall trends by estimating the average annual percent change using the Joinpoint regression program. Subgroup analyses were performed based on demographic and geographic factors. In the 22‐year study, there were 446 096 VHD deaths, accounting for 0.80% of all‐cause mortality (56 014 102 people) and 2.38% of the total cardiovascular mortality (18 759 451 people). Aortic stenosis recorded the highest mortality of VHD‐related death in both male (109 529, 61.74%) and female (166 930, 62.13%) populations. The AAMR of VHD has declined from 8.4 (95% CI, 8.2–8.5) to 6.6 (95% CI, 6.5–6.7) per 100 000 population. Similar decreasing AAMR trends were also seen for the VHD subtypes. Men recorded higher AAMR for aortic stenosis and aortic regurgitation, whereas women had higher AAMR for mitral stenosis and mitral regurgitation. Mitral regurgitation had the highest change in average annual percent change in AAMR. Conclusions The mortality rate of VHD among the US population has declined over the past 2 decades. This highlights the likely efficacy of increasing surveillance and advancement in the management of VHD, resulting in improved outcomes.
Effect of anti‐VEGF on retinal blood flow in diabetic mice using laser speckle flowgraphy
Su, Zheng Zhe Steven, Htoon, Hla Myint , Agrawal, Rupesh , Schmetterer, Leopold , Agrawal, Rupesh , Ang, Bryan C H , Balne, Praveen Kumar , Tun, Sai Bo Bo , Barathi, Veluchamy A.

Mayo Clinic

Acta Ophthalmologica | April 4, 2024 | Volume: 102 | Issue: 6 | Pages: No page available

10.1111/aos.16672 | PMID 38572815 Get It

Abstract Purpose To assess intra‐ (repeatability) and inter‐observer (reproducibility) variability of laser speckle flowgraphy (LSFG) for retinal blood flow (RBF) measurement in 20 eyes of wild type (C57BL/6J) mice and effect of intravitreal Aflibercept on RBF in optic nerve head (ONH) region of 10 eyes of Ins2 (Akita) diabetic mice. Methods ‘Mean blur rate (MBR)’ was measured for all quadrants of tissue area (MT), vessel (MV) and total area (MA) of ONH region. Changes in MT were analysed at each timepoint. Repeatability was evaluated by measuring MBR variability without changing mouse head position, and reproducibility after resetting mouse head position by another operator. Coefficient of repeatability (CR) through Bland–Altman plot method coefficient of variation (COV) and Intraclass correlation coefficient (ICC) was calculated. Intravitreal Aflibercept (1 μg) was administered to Akita eyes and intraocular pressure (IOP) was measured using a tonometer at baseline, day 7, 14, 21 and 28 post‐injection. Hurvich and Tsai's criterion was used. Results Coefficient of repeatability values of repeatability and reproducibility for all quadrants were within limits of agreement. Reliability was excellent (ICC 0.98–0.99) and reproducibility was moderate to excellent (ICC 0.64–0.96). There was a non‐significant IOP increase in all Akita eyes at Day 28 ( p > 0.05), and significant increase in MT in all quadrants at Day 21 and superior, inferior and temporal quadrants at Day 28 ( p < 0.05). Conclusion Laser speckle flowgraphy demonstrates excellent repeatability and moderate to excellent reproducibility in measuring RBF. Intravitreal Aflibercept injection results in a significant increase in MT up to 28 days post‐injection without significant increase in IOP.
Ventricular Arrhythmia Mortality in Patients with Heart Failure in the United States: Are There Differences Based on Race and Geography?
Tan, Min Choon , San, Boon Jian , Z, Justin Lee, Cha, Yong‐Mei , Scott, Luis R. , Sorajja, Dan , Russo, Andrea M. , Tan, Min C

Mayo Clinic

No container title available | March 31, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.171188076.69214399/v1 Get It

Trends and Disparities in Cardiovascular Death in Sarcoidosis: A Population‐Based Retrospective Study in the United States From 1999 to 2020
Tan, Min Choon , Yeo, Yong Hao , Mirza, Noreen , San, Boon Jian , Tan, Jian Liang , Lee, Justin Z. , Mazzarelli, Joanne K. , Russo, Andrea M. , Yeo, Yong Hao , Tan, Min C

Mayo Clinic

Journal of the American Heart Association | March 27, 2024 | Volume: 13 | Issue: 7 | Pages: No page available

10.1161/jaha.123.031484 | PMID 38533928 Get It

Background Despite significant cardiac involvement in sarcoidosis, real‐world data on death due to cardiovascular disease among patients with sarcoidosis is not well established. Methods and Results We queried the Centers for Disease Control and Prevention's Wide‐Ranging Online Data for Epidemiologic Research database for data on patients with sarcoidosis aged ≥25 years from 1999 to 2020. Diseases of the circulatory system except ischemic heart disease were listed as the underlying cause of death, and sarcoidosis was stated as a contributing cause of death. We calculated age‐adjusted mortality rate (AAMR) per 1 million individuals and determined the trends over time by estimating the annual percentage change using the Joinpoint Regression Program. Subgroup analyses were performed on the basis of demographic and geographic factors. In the 22‐year study period, 3301 cardiovascular deaths with comorbid sarcoidosis were identified. The AAMR from cardiovascular deaths with comorbid sarcoidosis increased from 0.53 (95% CI, 0.43–0.65) per 1 million individuals in 1999 to 0.87 (95% CI, 0.75–0.98) per 1 million individuals in 2020. Overall, women recorded a higher AAMR compared with men (0.77 [95% CI, 0.74–0.81] versus 0.58 [95% CI, 0.55–0.62]). People with Black ancestry had higher AAMR than people with White ancestry (3.23 [95% CI, 3.07–3.39] versus 0.39 [95% CI, 0.37–0.41]). A higher percentage of death was seen in the age groups of 55 to 64 years in men (23.11%) and women (21.81%), respectively. In terms of US census regions, the South region has the highest AAMR from cardiovascular deaths with comorbid sarcoidosis compared with other regions (0.78 [95% CI, 0.74–0.82]). Conclusions The increase of AAMR from cardiovascular deaths with comorbid sarcoidosis and higher cardiovascular mortality rates among adults aged 55 to 64 years highlight the importance of early screening for cardiovascular diseases among patients with sarcoidosis.
Patient Access of Their Radiology Reports Before and After Implementation of 21st Century Cures Act Information-Blocking Provisions at a Large Multicampus Health System
Petty, Skye A. Buckner, Schmitz, John J. , Varner, Jacob, Metcalfe, Allie M., Pollock, Jordan Riley , Tan, Nelly

Mayo Clinic

American Journal of Roentgenology | March 27, 2024 | Volume: 222 | Issue: 6 | Pages: No page available

10.2214/ajr.23.30343 | PMID 38534191 Get It

How have US colorectal cancer mortality trends changed in the past 20 years?
Tan, Jia Yi , Ng, Wern Lynn , Brady, Justin T. , Yeo, Yong Hao , Fong, Zhi Ven

Mayo Clinic

International Journal of Cancer | March 25, 2024 | Volume: 155 | Issue: 3 | Pages: 493-500

10.1002/ijc.34926 | PMID 38525799 Get It

Abstract In the last two decades, colorectal cancer (CRC) mortality has been decreasing in the United States. However, the mortality trends for the different subtypes of CRC, including different sides of colon, rectosigmoid, and rectal cancer remain unclear. We analyzed the mortality trends of different subtypes of CRC based on Centers for Disease Control and Prevention's Wide‐Ranging Online Data for Epidemiologic Research data from 1999 to 2020. We calculated age‐adjusted mortality rates (AAMR) per 100,000 individuals and examined the trends over time by estimating the average annual percent change (AAPC) using the Joinpoint Regression Program. Our study shows that the overall CRC rates decreased significantly from 26.42 to 15.98 per 100,000 individuals, with an AAPC of −2.41. However, the AAMR of rectosigmoid cancer increased significantly from 0.82 to 1.08 per 100,000 individuals, with the AAPC of +1.10. Men and Black individuals had the highest AAMRs respectively (23.90 vs. 26.93 per 100,000 individuals). The overall AAMR of CRC decreased for those aged ≥50 years but increased significantly from 1.02 to 1.58 per 100,000 individuals for those aged 15–49 years, with an AAPC of +0.75. Rural populations had a higher AAMR than the urban populations (22.40 vs. 19.60 per 100,000 individuals). Although overall CRC mortality declined, rising trends in young‐onset CRC and rectosigmoid cancer warrant attention. Disparities persist in terms of sex, race, and geographic region, and urbanization level, emphasizing the need for targeted public health measures.